Kingworld Medicines Group (HKSE:01110) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 07, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

Kingworld Medicines Group (HKSE:01110) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Kingworld Medicines Group EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Executives

Chan Lok San	2101 Beneficial owner
Zhao Li Sheng	2101 Beneficial owner
Sinopharm Capital Limited	2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p.	2101 Beneficial owner
Sun Hill Capital Investments Limited	2201 Interest of corporation controlled by you
Wu Aimin	2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited	2201 Interest of corporation controlled by you
Wu Aimin	2201 Interest of corporation controlled by you

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines